Here are three recent news updates on key gastroenterology and endoscopy companies.
PAION initiated a dedicated safety study of Remimazolam in American Society of Anesthesiologists classification III to IV patients undergoing colonoscopy as part of the U.S. Phase III program.
EndoGastric Solutions secured additional financing of up to $50 million.
Olympus launched EZDilate multi-stage endoscopic balloon dilator.